Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of ZFP69B mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP69B mRNA | CTD | PMID:20106945 and PMID:21632981 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of ZFP69B mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of ZFP69B protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ZFP69B mRNA | CTD | PMID:21632981 | avobenzone | decreases expression | EXP | | 6480464 | avobenzone results in decreased expression of ZFP69B mRNA | CTD | PMID:31016361 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ZFP69B mRNA | CTD | PMID:20106945 more ... | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of ZFP69B mRNA | CTD | PMID:32234424 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ZFP69B mRNA | CTD | PMID:27685785 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZNF643 gene] | CTD | PMID:28238834 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ZNF643 mRNA | CTD | PMID:27392435 | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of ZNF643 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of ZFP69B mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of ZFP69B mRNA | CTD | PMID:20106945 more ... | cyclosporin A | affects expression | EXP | | 6480464 | Cyclosporine affects the expression of ZFP69B mRNA | CTD | PMID:25562108 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | fonofos | decreases methylation | EXP | | 6480464 | Fonofos results in decreased methylation of ZFP69B promoter | CTD | PMID:22847954 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of ZFP69B mRNA | CTD | PMID:27188386 | N-Nitrosopyrrolidine | increases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in increased expression of ZFP69B mRNA | CTD | PMID:32234424 | parathion | decreases methylation | EXP | | 6480464 | Parathion results in decreased methylation of ZFP69B promoter | CTD | PMID:22847954 | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of ZFP69B mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFP69B mRNA | CTD | PMID:27188386 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of ZFP69B mRNA | CTD | PMID:21632981 | quinolin-8-ol | decreases expression | EXP | | 6480464 | Oxyquinoline results in decreased expression of ZFP69B mRNA | CTD | PMID:21632981 | resorcinol | decreases expression | EXP | | 6480464 | resorcinol results in decreased expression of ZFP69B mRNA | CTD | PMID:22623647 | S-(1,2-dichlorovinyl)-L-cysteine | increases expression | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in increased expression of ZFP69B mRNA | CTD | PMID:33725128 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide analog results in increased expression of ZNF643 mRNA | CTD | PMID:25895662 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ZFP69B mRNA | CTD | PMID:31533062 | terbufos | decreases methylation | EXP | | 6480464 | terbufos results in decreased methylation of ZFP69B promoter | CTD | PMID:22847954 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of ZFP69B mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFP69B mRNA | CTD | PMID:27188386 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of ZFP69B mRNA | CTD | PMID:28818685 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ZFP69B mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFP69B mRNA | CTD | PMID:27188386 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZFP69B mRNA | CTD | PMID:24383497 more ... | |